Company: FTII
Filing Date: 2025-02-14
Form Type: S-4
Source: 0001493152-25-006997
Chunk: 268

Company: FutureTech II Acquisition Corp.
Filing Date: 2025-02-14
Form: S-4
Chunk 268
---
 Trust Account (net of approximately $3,450,000 of deferred underwriting commissions), the FutureTech Board determined
that this requirement was met. The FutureTech

Board determined that the terms of
the Business Combination, which were negotiated at arms-length, were advisable and in the best interests of FutureTech and its stockholders.

Ownership Following the Business
Combination

As of the date of this proxy
statement/prospectus, there are (i) 4,289,961 shares of FutureTech Common Stock issued and outstanding, consisting of the 520,075 Private
Placement Shares, 2,875,000 founder shares, 779,886 public shares, and 115,000 representative shares and (ii) 12,020,075 Warrants
issued and outstanding, consisting of the 520,075 Private Placement Warrants held by the Sponsor and 11,500,000 Public Warrants. Each
whole warrant entitles the holder thereof to purchase one share of Class A Common Stock at $11.50 per share. Therefore, as of the date
of this proxy statement/prospectus (without giving effect to the Business Combination, or the PIPE Investment), FutureTech’s fully
diluted share capital would be 16,310,036 FutureTech Common Stock equivalents.

Upon completion
of the Business Combination, we anticipate that: (1) shares issued to existing holders of Longevity Common Stock (including holders receiving
shares issued in connection with the Target Acquisitions) will represent an ownership interest of approximately 36.2% of the issued and
outstanding Common Stock on a fully diluted basis, (2) shares issued to FutureTech public stockholders will represent an ownership interest
of approximately 44.0% of the issued and outstanding FutureTech Common Stock on a fully diluted basis, (3) shares issued to the Sponsor
Persons will represent an ownership interest of approximately 14.0% of the issued and outstanding FutureTech Common Stock on a fully diluted
basis, (4) shares issued to the Sponsor pursuant to the Sponsor Convertible Promissory Note, assuming the respective exercise of the option
to convert amounts owed under the notes into FutureTech Common Stock at the Closing, will represent an ownership interest of 1.3% of the
issued and outstanding FutureTech Common Stock on a fully diluted basis, (5) shares issued to the PIPE Investor in the PIPE Investment
will represent an ownership interest of approximately 3.6% of the issued and outstanding FutureTech